Error loading player: No playable sources found

AM23-ST-20-O

AM23-ST-20-O: The Unextinct Dinosaurs, Whole Blood in Civilian Transfusion Practice (Enduring)

Credits
1 General Continuing Education (GEN) | 1 Florida Lab Personnel (FLP) | 1 California Nurse (CN) | 1 California Lab Personnel (CLP) | 1 Physician (PHY)
$30
Standard Price
Members save $5

The session will start with how low titer group O whole blood (LTOWB) has become part of the 21st-century massive transfusion protocol (MTP) of both adult and pediatric trauma and non-trauma settings with a focus on North America. The session will demonstrate how to design and implement an LTOWB program in both the blood center and transfusion service. There will be a discussion on matters important to blood centers, including the use of platelet-sparing leukoreduction filters, what is considered “low titer,” the possibility of manufacturing unused units into components, and recruitment concerns of a dedicated program. Transfusion service logistics will be covered, including availability and wastage. Rh (D) considerations, particularly in women of childbearing age and pediatric patients, will be an area of focus. The use of LTOWB prehospital and in-hospital and effects on patient outcomes will be addressed. The session will conclude with the future directions of LTOWB.

Learning Objectives

  • Discuss the evolution of low-titer group O whole blood in the 21st century as part of the massive transfusion protocol in both adult and pediatric trauma and nontrauma patient with a focus on North America
  • Demonstrate how to design and implement a LTOWB program in both the blood center and transfusion service
  • Describe blood center logistics including recruiting the right donors
  • Evaluate transfusion service logistics including Rh considerations of women in childbearing years and pediatric patients.
  • Assess prehospital vs. in hospital transfusions and effects on outcomes

Moderator & Speaker

Speaker Image for Richard Gammon
Medical Director, OneBlood

Speaker

Speaker Image for Amit Tayal
Director, Blood Bank and Stem Cell Laboratory, Assistant Professor, West Virginia University School of Medicine and Robert C. Byrd Health Sciences Center

Tracks

Related Products

Thumbnail for AM23-MN-11-O: The Science…or Not Behind Deferrals of Blood Donors With a History of Cancer (Enduring)
AM23-MN-11-O: The Science…or Not Behind Deferrals of Blood Donors With a History of Cancer (Enduring)
The Food and Drug Administration (FDA) and Association for the Advancement of Blood and Biotherapies (AABB) leave eligibility decisions to defer donors with a history of cancer to the medical director’s discretion…
Thumbnail for AM24-MN-08-O: Oral Abstracts - Patient Blood Management (Enduring)
AM24-MN-08-O: Oral Abstracts - Patient Blood Management (Enduring)
Oral abstracts about patient blood management…
Thumbnail for AM24-ST-29-O: Case Studies: Cyber Threats in Healthcare (Enduring)
AM24-ST-29-O: Case Studies: Cyber Threats in Healthcare (Enduring)
Join us for an essential panel discussion on cybersecurity in healthcare, where real-world insights and expert analysis come together to enhance your organization's defenses. This session features three distinguished speakers from hospitals and blood centers that have faced cybersecurity attacks…